Open access · OA
via OpenAlex
Frailty: understanding the difference between age and ageing
Emily H Gordon, Ruth E. Hubbard
Age and Ageing · 2022 · ▲ 108 citations
Abstract
In the past, illness and dependence were viewed as inevitable consequences of old age. Now, we understand that there is a difference between age (the passing of chronological time) and ageing (the increased risk of adverse outcomes over time). Over the last 50 years, 'frailty' research has established that ageing is heterogeneous, variable and malleable. Significant advances have been made in frailty measurement (description of clinical features and development of clinical models), mechanisms (insights into pathogenesis) and management (development of interventions to reduce and/or prevent progression). Subsequently, the concept of frailty has informed health policy and clinical practice and started to change perceptions of older age held by the general public and the health sector. Here, we overview key achievements in frailty research and clinical practice and highlight the considerable number of known unknowns that may be addressed in the future.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/ageing/afac185
- Canonical
- link ↗
- Fetched
- 2026-07-25 MST
Cite this
APA
Gordon, E.H., & Hubbard, R.E. (2022). Frailty: understanding the difference between age and ageing. <em>Age and Ageing</em>. https://doi.org/10.1093/ageing/afac185
Vancouver
Gordon EH, Hubbard RE. Frailty: understanding the difference between age and ageing. Age and Ageing. 2022. doi:10.1093/ageing/afac185.
BibTeX
@article{emily2022Frailt,
title = {Frailty: understanding the difference between age and ageing},
author = {Emily H Gordon and Ruth E. Hubbard},
journal = {Age and Ageing},
year = {2022},
doi = {10.1093/ageing/afac185},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Thomas Jefferson University 2021
Open access · US-GOV
Third-Party COVID-19-Specific Cytotoxic T Lymphocytes for the Treatment of Elderly and High-Risk Patients With COVID-19 Infection
Mechanisms of Ageing and Development 2019
Open access · CC-BY
Geroprotectors: A role in the treatment of frailty
BMC Musculoskeletal Disorders 2017
Open access · CC-BY
An overview of osteoporosis and frailty in the elderly
University of Utah 2026
Open access · US-GOV
Integration of Lesion-tailored, Fundus-controlled Perimetry Into Routine Clinical Care for Patients With Geographic Atrophy (GA) Receiving Pegcetacoplan Treatment in Accordance With the Approved Label.
Gerontology 2019
Citation only
Frailty Assessment in Animal Models
Nutrition and Healthy Aging 2020
Open access · CC-BY